Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...
Hosted on MSN
Popular insulin medications and how they are used
Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...
Toujeo delivers 300 units/mL of insulin glargine in a compact prefilled pen for adults living with type 2 diabetes in the US. Anyone holding Sanofi S.A. stock (NASDAQ: SNY, ISIN FR0000120578) should ...
The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus. The Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results